Colony Group’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $37.6M | Sell |
108,145
-2,060
| -2% | -$716K | 0.56% | 36 |
|
|
2023
Q2 | $38.8M | Sell |
110,205
-2,241
| -2% | -$789K | 0.55% | 39 |
|
|
2023
Q1 | $35.4M | Buy |
112,446
+18,451
| +20% | +$5.81M | 0.52% | 42 |
|
|
2022
Q4 | $27.1M | Buy |
93,995
+7,769
| +9% | +$2.24M | 0.38% | 63 |
|
|
2022
Q3 | $25M | Buy |
86,226
+12,368
| +17% | +$3.58M | 0.44% | 50 |
|
|
2022
Q2 | $20.8M | Buy |
73,858
+9,273
| +14% | +$2.61M | 0.36% | 63 |
|
|
2022
Q1 | $16.9M | Buy |
+64,585
| New | +$16.9M | 0.25% | 96 |
|
|
2021
Q1 | – | Sell |
-1,421
| Closed | -$336K | – | 789 |
|
|
2020
Q4 | $336K | Sell |
1,421
-982
| -41% | -$232K | 0.01% | 583 |
|
|
2020
Q3 | $654K | Sell |
2,403
-55
| -2% | -$15K | 0.02% | 429 |
|
|
2020
Q2 | $714K | Sell |
2,458
-18
| -0.7% | -$5.23K | 0.02% | 394 |
|
|
2020
Q1 | $589K | Sell |
2,476
-189
| -7% | -$45K | 0.02% | 419 |
|
|
2019
Q4 | $584K | Buy |
2,665
+7
| +0.3% | +$1.53K | 0.01% | 498 |
|
|
2019
Q3 | $450K | Sell |
2,658
-54
| -2% | -$9.14K | 0.01% | 507 |
|
|
2019
Q2 | $497K | Sell |
2,712
-3
| -0.1% | -$550 | 0.02% | 506 |
|
|
2019
Q1 | $499K | Buy |
+2,715
| New | +$499K | 0.02% | 397 |
|
|
2016
Q1 | – | Sell |
-567
| Closed | -$71K | – | 639 |
|
|
2015
Q4 | $71K | Sell |
567
-70
| -11% | -$8.77K | 0.01% | 450 |
|
|
2015
Q3 | $66K | Buy |
637
+567
| +810% | +$58.7K | 0.01% | 443 |
|
|
2015
Q2 | $9K | Hold |
70
| – | – | ﹤0.01% | 609 |
|
|
2015
Q1 | $8K | Hold |
70
| – | – | ﹤0.01% | 600 |
|
|
2014
Q4 | $8K | Hold |
70
| – | – | ﹤0.01% | 611 |
|
|
2014
Q3 | $8K | Hold |
70
| – | – | ﹤0.01% | 639 |
|
|
2014
Q2 | $7K | Hold |
70
| – | – | ﹤0.01% | 584 |
|
|
2014
Q1 | $5K | Hold |
70
| – | – | ﹤0.01% | 668 |
|
|
2013
Q4 | $5K | Buy |
+70
| New | +$5K | ﹤0.01% | 584 |
|